跳至主要内容
临床试验/NCT06151613
NCT06151613招募中不适用

Non-invasive Electrophysiological Monitoring in High Risk Pregnancies at the Obstetric High Care: the NIEM-O Study

Maxima Medical Center2 个研究点 分布在 1 个国家目标入组 1,911 人开始时间: 2023年11月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,911
试验地点
2
主要终点
Incidence of perinatal mortality and major neonatal morbidity

研究概览

简要总结

The goal of this single centre cohort intervention study with historical controls, is to investigate the effect of implementing continuous antepartum electrophysiological CTG (eCTG) monitoring at the Obstetric High Care (OHC), on perinatal and maternal outcomes and obstetric care.

The main aim is to investigate the effect of both monitoring methods on:

  • primary outcome: perinatal outcomes (a composite of perinatal mortality or major neonatal morbidity) until hospital discharge
  • secondary outcomes: Maternal mortality, neonatal morbidity, satisfaction for both patient and caregiver, duration of pregnancy, switch of monitoring method, duration of admission to the OHC, timing (planned or emergency) and number of obstetric interventions (such as caesarean section), and admission and duration of admission to the NICU (neonatal intensive care unit).

Eligible women will be prospectively included in the cohort receiving standard treatment: CTG monitoring intermittent up to three times a day. From these eligible women, a random sample (464) of the prospective cohort (511) will be offered to receive a new monitoring method: 24/7 eCTG monitoring. In order to strengthen the comparison between the two groups (eCTG and standard treatment), additional data from 1400 women who received standard treatment in 2014-2019 will be collected retrospectively.

详细描述

Pregnant women in need for maternal and/or fetal monitoring are hospitalized at the obstetric high care (OHC) of Máxima Medical Center (MMC). They are monitored for up to three times a day with conventional cardiotocography (CTG). In the meantime they reside at the OHC, but the status of the fetus and uterine activity (UA) is not monitored. Nemo Healthcare developed a wireless abdominal electrode patch for measuring fetal heart rate (FHR) and UA: The Nemo Fetal Monitoring System (NFMS). Previous research on non-invasive electrophysiological CTG (eCTG) has yielded promising results in monitoring FHR and UA both during pregnancy and labor. With the use of eCTG technology, safe continuous 24/7 monitoring is possible, which is not possible with conventional cardiotocography. The investigators hypothesize that by introducing continuous antepartum eCTG monitoring perinatal and maternal outcomes will improve.

The investigators aim to include 1911 pregnant women ≥18 years old with a singleton pregnancy between 23+0 and 32+0 weeks of gestation requiring hospitalization on the OHC for maternal or fetal surveillance (including 1400 historical controls).

Additional objectives: The collected NFMS and demographic data will be used to develop and verify a mathematical model for the prediction of time until (preterm) birth, which may be used in clinical practice to reduce unnecessary OHC admissions and facilitate a better timing of interventions. Furthermore, data collected in this study (NFMS, accelerometric, annotated ultrasound) will be used for the development and verification of a mathematical model for the automated detection of fetal movements in NFMS data. This latter model might provide new opportunities in non-invasive monitoring of fetal health.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • ≥18 years old
  • Singleton pregnancy ≥23+0 weeks of gestation
  • Requiring hospitalization to the OHC for maternal or fetal surveillance (i.e. imminent preterm delivery(PPI), PE, HELLP, pregnancy induced hypertension (PIH), FGR, fetal distress, vaginal blood loss, fetal congenital anomalies)
  • Parents wishing for fetal monitoring

排除标准

  • Multiple pregnancy
  • Insufficient knowledge of Dutch or English language
  • Contraindications to abdominal patch placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper)
  • Women connected to an external or implanted electrical stimulator (e.g. a pacemaker - exclusion due to possible signal interference)
  • Fetal and/or maternal cardiac disease (i.e. arrhythmia, congenital defect)
  • Treatment plan (with intervention planned within 24 hours after admission) already made before inclusion is completed
  • Women admitted with a clinical diagnosis of sepsis with hypotension (i.e. septic shock).

结局指标

主要结局

Incidence of perinatal mortality and major neonatal morbidity

时间窗: during admission (immediately after birth until hospital discharge) or until at least 4 weeks after birth

A composite outcome consisting of: 1. Incidence of perinatal mortality and/or 2.Incidence of a major neonatal morbidity (defined as either: Intraventricular hemorrhage (IVH) grade three or more, Periventricular leukomalacia (PVL) grade two or more, Moderate or severe bronchopulmonary dysplasia (BPD), Necrotizing enterocolitis (NEC) grade two or more, or Retinopathy of prematurity (ROP) necessitating laser therapy).

次要结局

  • Incidence of neonatal morbidity(From inclusion assessed up to 6 months after inclusion)
  • Assesment using a surveys (D-QUEST) to measure patient satisfaction(At discharge, assessed up to 1 month.)
  • Duration of pregnancy in days(Measured from first day of pregnancy until birth, pregnancy period must be related to pregnancy at time of inclusion in the study. Assessed up to 5,5 months after inclusion.)
  • Switch of monitoring method from eCTG to CTG monitoring(From inclusion assessed up to 6 months after inclusion)
  • Admission (yes/no) to the NICU (neonatal intensive care unit)(From inclusion assessed up to 6 months after inclusion)
  • Incidence of maternal mortality(From moment of inclusion until six weeks after giving birth)
  • Assesment using a survey (EQ5D5L) to measure patient satisfaction(EQ5D5L questionnaire is given on day 1 of the admission (day 1 after inclusion). and assessed up to 1 month.)
  • Assesment using one survey (Browns survey) to measure caregiver satisfaction(Caregivers are invited to fill in the questionnaire at baseline and at 1 year)
  • Duration of admission to the Obstetric High Care in days(From inclusion assessed up to 6 months after inclusion)
  • Duration of admission to the NICU (neonatal intensive care unit) in days.(From inclusion assessed up to 6 months after inclusion)
  • Timing of obstetric interventions (caesarean section)(From inclusion assessed up to 6 months after inclusion)
  • Number of obstetric interventions (caesarean section)(From inclusion assessed up to 6 months after inclusion)

研究者

发起方
Maxima Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nadine de Klerk

MD, researcher, PhD candidate

Maxima Medical Center

研究点 (2)

Loading locations...

相似试验